R. Fraser et al. / Journal of Organometallic Chemistry 840 (2017) 11e22
13
Fig. 4. NHC ligands used in this study.
CD3CN using the deuterated solvent peak as internal reference. The
1H and 13C NMR spectra were measured at 300.1 and 75.5 MHz,
respectively. IR spectra were recorded on a Perkin Elmer Spectrum
RXI FT-IR spectrophotometer as KBr pellets or in hexane and only
the vibration bands in the carbonyl-stretching region (ca. 1500-
2200 cmꢁ1) are reported.
ylidene L2 (0.481 g, 3.0 mmol) was added to photo-irradiated
MeCpMn(CO)3 (0.654 g, 3.0 mmol). A single yellow solid product
of complex 4 was isolated (yield: 0.255 g; 27%).1H NMR, ppm
(CD3CN):
d
6.85 (s, 1H, NCH¼CHN), 6.83 (s, 1H, NCH¼CHN), 3.96 (s,
2H, Cp), 3.86 (s, 3H, NCH3), 3.85 (s, 2H, Cp), 3.76 (s br, 2H,
NCH(CH3)2), 2.89 (s, 3H, Cp-CH3), 1.33 (d, 6H, JHH ¼ 6.3, NCH(CH3)2).
13C{1H} NMR, ppm:
d
235.1 Mn(CO)2, 195.0 NCN, 124.9 NC¼CN,
2.2. Synthesis of complexes 1-6
124.1 NC¼CN, 34.7 Cp-CH3, 102.8 Cp, 81.9 Cp, 80.4 Cp, 60.5 NCH3,
52.4 NCH(CH3)2, 13.7 NCH(CH3)2. IR (cmꢁ1): 1943
HRESIþ-MS, m/z: 317.1081 (calcd. 317.1062).
n(CO), 1852 n(CO).
2.2.1. Synthesis of 1, CpMn(CO)2L1
All complexes were synthesised according to a similar meth-
odology as reported by Lugan [4]. CpMn(CO)3 (0.612 g, 3.0 mmol)
was dissolved in 40 ml of dry THF and irradiated for 60 min at room
temperature. Imidazol-2-ylidene L1 (0.714 g, 3.0 mmol) was added
to the reaction mixture via cannula and the reaction allowed to stir
for 90 min. The reaction colour turned to deep brown and the
mixture was subsequently filtered through a small aluminium ox-
ide column. The solvent was evaporated, the product redissolved
and purified with column chromatography with hexane:ether
eluent to recover 1 as an orange oil. Yield (0.267 g (31%) %) 1H
2.2.5. Synthesis of 5, CpMn(CO)2L3
A similar methodology as for 1 was followed. Imidazol-2-
ylidene L1 (0.801 g, 3.0 mmol) was added to photo-irradiated
MeCpMn(CO)3 (0.612 g, 3.0 mmol). A single yellow solid product
of complex 3 was isolated (yield: 0.381 g; 35%). 1H NMR, ppm
(CD3CN):
NHC¼CHN), 4.44 (m, 2H, NCH2Bn); 4.38 (s, 5H, Cp), 3.75 (s, 3H,
NCH3), 3.03 (m, 2H, NCH2CH2Ph). 13C{1H} NMR, ppm:
235.2
Mn(CO)2, 195.1 NCN, 138.9 Ph(ipso), 129.3 Ph(meta), 129.0 Ph(ortho)
d
7.45 (s, 1H, NHC¼CHN), 7.34 (s br, 5H, Ph), 7.26 (s, 1H,
d
,
NMR(CD3CN):
d
7.33 (s, 1H, NCH¼CHN), 7.30 (s, 1H, NHC¼CHN),
127.0 Ph(para), 124.5 NC¼CN, 122.1 NC¼CN, 82.7Cp, 64.4 NCH3, 52.0
4.44 (s, 5H, Cp), 4.27 (q, 2H, JHH ¼ 7.3, NCH2CH3), 3.75 (s, 3H, NCH3),
NCH2Bn, 40.8 NCH2CH2Ph,. IR (cmꢁ1): 1921
HRESIþ-MS, m/z: 365.1033 (calcd. 365.1062).
n(CO), 1855 n(CO).
1.30 (t, 3H,, JHH ¼ 7.3, NCH2CH3) 13C{1H} NMR:
d 235.22 Mn(CO)2,
195.7 NCN, 124.6 NC¼CN, 121.5 NC¼CN, 82.6 Cp, 65.4 NCH3, 45.5
NCH2CH3, 16.7 NCH2CH3. IR (cmꢁ1): 1922
HRESIþ-MS, m/z: 287.0513 (calcd. 287.0592).
n
(CO), 1856
n
(CO).
2.2.6. Synthesis of 6, MeCpMn(CO)2L3
A similar methodology as for 1 was followed. Imidazol-2-
ylidene L1 (0.801 g, 3.0 mmol) was added to photo-irradiated
MeCpMn(CO)3 (0.654 g, 3.0 mmol). A single yellow solid product
of complex 6 was isolated (yield: 0.374 g; 33%). 1H NMR, ppm
2.2.2. Synthesis of 2, MeCpMn(CO)2L1
A similar methodology as for 1 was followed. Imidazol-2-
ylidene L1 (0.714 g, 3.0 mmol) was added to photo-irradiated
MeCpMn(CO)3 (0.654 g, 3.0 mmol). A single brown-orange oily
product of complex 2 was isolated. Yield: 0.271 g (30%) 1H NMR,
(CD3CN):
d
7.37 (s br, 4H, Ph), 7.46 (s, 1H NHC¼CHN), 7.25 (s, 1H
NCH¼CHN), 4.46 (m, 2H, NCH2Bn), 4.26 (s br, 5H, Cp), 3.75 (s, 3H,
NCH3) 3.05 (m, 2H, NCH2CH2Ph), 2.51 (s, 3H, Cp-CH3). 13C{1H} NMR,
ppm (CD3CN):
d
7.20 (s, 1H, NHC¼CHN), 7.15 (s, 1H, NHC¼CHN, 4.34
ppm:
d
Mn(CO) 235.3, 196.5 NCN, 124.6 NC¼CN, 122.2 NC¼CN,
(s br, 2H, NCH2CH3), 4.09 (s, 2H, Cp), 4.02 (s, 2H, Cp)), 3.36 (s, 3H,
138.9 Ph(ipso), 129.3 Ph(meta), 129.0 Ph(ortho), 127.0 Ph(para), 103.2 Cp,
NCH3), 2.86 (s, 3H, Cp-CH3), 1.48 (s br 3H, NCH2CH3). 13C{1H} NMR,
82.1 Cp, 80.4 Cp, 64.4 NCH3, 52.1 NCH2Bn, 40.8 NCH2CH2Ph,.35.6
ppm:
d
234.7 Mn(CO)2, 200.7 NCN, 129.0NC ¼ CN, 128.6 NC¼CN, Cp
Cp-CH3. IR (cmꢁ1): 1917 (CO). HRESIþ-MS, m/z:
n(CO), 1852 n
101.4, Cp 81.5, Cp 79.8, 65.0 NCH3; NCH2CH3 52.27, Cp-CH3 37.5,
379.1248 (calcd. 379.1218).
NCH2CH3 13.7. IR (cmꢁ1): 1918 (CO). HRESIþ-MS, m/z:
n(CO), 1852 n
303.0939 (calcd. 303.0905).
2.3. X-ray crystallography
2.2.3. Synthesis of 3, CpMn(CO)2L2
Data for complexes 3 and 6 and C1 were collected at 150 K on a
Bruker D8 Venture kappa geometry diffractometer, with duo I
sources, a Photon 100 CMOS detector and APEX II control software
using Quazar multi-layer optics, monochromated Mo-K radiation
and by means of a combination of and scans. Data reduction
A similar methodology as for 1 was followed. Imidazol-2-
ylidene L2 (0.0481 g, 3.0 mmol) was added to photo-irradiated
MeCpMn(CO)3 (0.612 g, 3.0 mmol). A single yellow solid product
of complex 3 was isolated (yield: 0.271 g; 30%).1H NMR, ppm
ms
a
f
u
(CD3CN):
5H, Cp), 3.76 (s, 3H, NCH3), 3.60 (m, 2H, NCH(CH3)2), 1.32 (s, 6H,
NCH(CH3)2). 13C{1H} NMR, ppm:
235.1 Mn(CO)2, 193.5 NCN,
d
7.42 (s, 1H, NHC¼CHN), 7.32 (s, 1H, NCH¼CHN), 4.45 (s,
was performed using SAINTþ and the intensities were corrected for
absorption using SADABS [12]. The structures were solved by
intrinsic phasing using SHELXTS and refined by full-matrix least
squares using SHELXTL and SHELXL-2013 [13]. In the structure
refinement, all hydrogen atoms were added in calculated positions
and treated as riding on the atom to which they are attached. All
nonhydrogen atoms were refined with anisotropic displacement
parameters, all isotropic displacement parameters for hydrogen
atoms were calculated as X ꢂ Ueq of the atom to which they are
d
124.90 NC¼CN, 118.7 NC¼CN, Cp 82.5, 67.5 NCH3, 51.9 NCH(CH3)2,
25.6 NCH(CH3)2. IR (cmꢁ1): 1922
z: 301.0789 (calcd. 301.0748).
n(CO), 1856 n
(CO). HRESIþ-MS, m/
2.2.4. Synthesis of 4, MeCpMn(CO)2L2
A similar methodology as for 1 was followed. Imidazol-2-